Patients who developed cancer from the DC/TBD NCI cohort presented different patterns of inheritance: 48.1% had AD-nonTINF2 disease, 29.6% had AR/XLR disease, 3.7% had TINF2-associated disease, and 18.7% had an unknown mode of inheritance (198). Here, TINF2 is linked to cancer.